Table I.
Correlation between S100 calcium binding protein A14 expression and clinicopathological features in serous ovarian carcinomas.
| Clinical and pathological features | Total, n (%) | Expression score | P-value |
|---|---|---|---|
| Age | 0.66 | ||
| ≤50 years | 43 (34.4) | 1.92±1.13 | |
| >50 years | 82 (65.6) | 2.01±0.99 | |
| Tumor family history | 0.84 | ||
| Yes | 38 (30.4) | 2.01±1.10 | |
| No | 87 (69.6) | 1.96±1.01 | |
| Tumor size | 0.13 | ||
| ≤5 cm | 58 (46.4) | 2.13±1.03 | |
| >5 cm | 67 (53.6) | 1.85±1.03 | |
| Neoadjuvant chemotherapy | 0.69 | ||
| Yes | 55 (44.0) | 2.02±0.97 | |
| No | 70 (56.0) | 1.94±1.09 | |
| Ascites | 0.59 | ||
| Yes | 105 (80.4) | 1.95±1.04 | |
| No | 20 (16.0) | 2.09±1.03 | |
| FIGO stage | 0.62 | ||
| I–II | 22 (17.6) | 2.09±1.25 | |
| III–IV | 103 (82.4) | 1.95±0.99 | |
| Tumor grade | 0.76 | ||
| 1–2 | 18 (14.4) | 1.91±1.16 | |
| 3 | 107 (85.6) | 1.99±1.02 | |
| Lymphatic metastasis | 0.39 | ||
| Yes | 39 (31.2) | 2.05±0.98 | |
| No | 55 (44.0) | 1.86±1.05 | |
| Unknown | 31 (24.8) | ||
| Omentum metastasis | 0.30 | ||
| Yes | 75 (60.0) | 2.06±1.01 | |
| No | 43 (34.4) | 1.85±1.01 | |
| Unknown | 7 (5.6) | ||
| Chemotherapy response | 0.02 | ||
| Resistant | 23 (18.4) | 1.82±0.96 | |
| Sensitive | 96 (76.8) | 1.33±0.87 | |
| Uncertain | 6 (4.8) |
FIGO, International Federation of Gynecology and Obstetrics.